NEW ANTIHYPERTENSIVE AGENT IN ESSENTIAL, STABLE HYPERTENSION

治疗原发性稳定高血压的新型抗高血压药

• 批准号: 3905557
• 负责人: G. ANDERSON
• 金额: --
• 依托单位: UPSTATE MEDICAL UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3905557
• 关键词: antihypertensive agents; cardiovascular disorder chemotherapy; drug administration routes; drug metabolism; human subject; human therapy evaluation; hypertension; saluretic; vasodilators

This project is a study of new orally effective vasodilator (BTS48465) in patients with essential hypertension. It is a reasonably safe agent which exerts a hypotensive action for as long as 24 hour. Studies of ANF are being conducted to help explain the natriuretic action of the drug.

本课题是对新型口服有效血管扩张剂(BTS48465)的研究。 在患有高血压的患者中。这是一种相当安全的制剂。 有长达24小时的降压作用。ANF的研究 正在进行以帮助解释该药物的利钠作用。